| Literature DB >> 35161479 |
Gesala Perez-Junkera1,2, Maialen Vázquez-Polo1,2, Francisco Javier Eizagirre3, Laura Benjumea3, Carlos Tutau4, Blanca Esteban5, Jonatan Miranda1,2, Idoia Larretxi1,2,6, Virginia Navarro1,2, Itziar Churruca1,2, Arrate Lasa1,2.
Abstract
The present work aimed to analyze, through the GlutenFreeDiet digital platform, the evolution over one year of the nutritional status, dietary profile and symptoms present among celiac people on a gluten-free diet (GFD) while receiving individualized dietary advice. Twenty-seven adults and thirty-one celiac children/adolescents participated in the study. This was then followed up by three visits, at diagnosis, and after 3 and 12 months (vt0, vt3 and vt12). Participants filled out dietary and gastrointestinal symptoms questionnaires. All patients received written personalized dietary advice from dietitians who interpreted data from the platform. Results obtained indicated that participants consumed proteins and lipids in excess and carbohydrates in defect. Low intakes of cereals, fruit and vegetables and high meat intakes were observed. However, gluten-free product (GFP) consumption and that of ultra-processed foods was reduced after 1 year in adults. Symptoms decreased after vt3 but recurred in vt12. Changes in ultra-processed foods and GFP intake, but lack of changes in the rest of the parameters suggested that the platform support was not effective enough. Even though the platform represents a useful tool for monitoring celiac patients and giving dietary advice, modules that require more continuous attention and nutritional education of patients should be provided for interventions to be more effective.Entities:
Keywords: celiac disease; digital platform; digitalized dietary assessment; gluten-free diet; nutritional education
Mesh:
Year: 2022 PMID: 35161479 PMCID: PMC8838721 DOI: 10.3390/s22030732
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1Patients included in the study. Vt0: visit at time 0, at diagnosis; vt3: visit after 3 months on a gluten-free diet; vt12: visit after 12 months on a gluten-free diet.
Energy and macronutrient daily intake of celiac adults and children (mean ± SD).
| Adults | Children and Adolescents | Adults vs. Children | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recommended Intake * | vt0 | vt3 | vt12 | vt0 | vt3 | vt12 | ||||||||
|
| 27 | 13 | 2 | vt0 vs. vt3 | vt0 vs. vt12 | 22 | 10 | 4 | vt0 vs. vt3 | vt0 vs. vt12 | Vt0 | Vt3 | Vt12 | |
|
| ±20% of EE | 1968.4 ± 607.4 | 2079.7 ± 474.0 | 1944.0 ± 97.7 | NS | NS | 1867.5 ± 517.4 | 2194.2 ± 393.5 | 1944.0 ± 97.7 | NS | NS | NS | NS | NS |
|
| 12.5 | 16.3 ± 3.6 | 19.6 ± 3.6 | 19.8 ± 2.2 | NS | NS | 16.3 ± 3.7 | 20.3 ± 3.5 | 19.8 ± 2.0 | <0.05 | NS | NS | NS | NS |
|
| 32.5 | 41.1 ± 7.8 | 36.6 ± 6.7 | 40.6 ± 4.6 | 0.08 | NS | 41.3 ± 7.4 | 36.0 ± 7.3 | 40.6 ± 4.6 | NS | NS | NS | NS | NS |
|
| <10 | 12.8 ± 6.8 | 12.1 ± 2.8 | 14.5 ± 2.6 | NS | NS | 12.0 ± 4.3 | 12.8 ± 2.9 | 14.5 ± 2.6 | NS | NS | NS | NS | NS |
|
| 55 | 40.5 ± 8.3 | 42.5 ± 7.0 | 36.3 ± 7.1 | NS | NS | 40.2 ± 8.3 | 42.7 ± 8.0 | 36.3 ± 7.1 | NS | NS | NS | NS | NS |
|
| <10 | 4.3 ± 2.2 | 3.7 ± 1.2 | 4.1 ± 0.1 | NS | NS | 4.6 ± 2.3 | 3.8 ± 1.1 | 4.1 ± 0.1 | NS | NS | NS | NS | NS |
|
| 14 g/1000 kcal | 21.6 ± 11.2 | 26.3 ± 11.6 | 25.3 ± 7.1 | 0.1 | NS | 19.2 ± 10.0 | 25.9 ± 9.3 | 25.3 ± 7.1 | 0.06 | NS | NS | <0.05 | NS |
|
| <300 | 298.8 ± 132.3 | 302.7 ± 77.0 | 378.3 ± 125.2 | NS | NS | 296.3 ± 138.9 | 326.5 ± 65.5 | 378.3 ± 125.2 | NS | NS | NS | NS | NS |
Abbreviations: Vt0 = visit at time 0, at diagnosis; vt3 = visit after 3 months on a gluten-free diet; vt12 = visit after 12 months on a gluten-free diet; EE = Energy Expenditure. p < 0.05: Statistically significant; NS = Not Significant. * Recommended contribution to a balanced diet proposed by the Federation of Spanish Societies of Nutrition and Dietetics (FESNAD) and Spanish Society for Community Nutrition (SENC) [57,58].
Food group consumption frequency of celiac adults and children that took part in the study (mean ± SD).
| Adults | Children and Adolescents | Adults vs. Children | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Recommended Daily Portion Intake * | vt0 | vt12 | vt0 | vt12 | ||||||
|
| 22 | 4 | vt0 vs. vt12 | 31 | 16 | vt0 vs. vt12 | vt0 | vt12 | ||
|
| Dairy | 2–4 | 2.6 ± 1.4 | 3.2 ± 0.3 | NS | 2.7 ± 1.3 | 2.5 ± 0.6 | NS | NS | NS |
| Cereals | 4–6 | 2.6 ± 1.4 | 2.7 ± 0.8 | NS | 3.8 ± 1.9 | 2.7 ± 1.5 | 0.098 | <0.05 | NS | |
| Vegetables | 2 | 1.3 ± 1.4 | 2.0 ± 1.3 | NS | 0.8 ± 0.5 | 0.9 ± 0.6 | NS | <0.05 | <0.05 | |
| Fruits | 3 | 2.3 ± 1.6 | 2.2 ± 1.5 | NS | 1.7 ± 1.3 | 2.0 ± 1.1 | NS | NS | NS | |
| Oils | 3–6 | 2.5 ± 1.2 | 2.7 ± 2.3 | NS | 2.1 ± 1.4 | 2.4 ± 1.3 | NS | NS | NS | |
|
| Meat | 3–4 | 6.2 ± 2.5 | 4.5 ± 1.3 | 0.1 | 7.2 ± 3.5 | 6.5 ± 1.4 | <0.01 | NS | NS |
| Fish | 3–4 | 3.5 ± 2.3 | 4.3 ± 1.4 | NS | 3.1 ± 1.6 | 3.4 ± 1.6 | NS | NS | NS | |
| Eggs | 3–4 | 2.9 ± 2.5 | 3.0 ± 1.4 | NS | 2.7 ± 1.2 | 2.8 ± 0.6 | NS | NS | NS | |
| Legumes | 2–4 | 1.9 ± 1.3 | 1.7 ± 1.2 | NS | 2.6 ± 1.2 | 2.5 ± 0.9 | NS | 0.06 | 0.1 | |
| Nuts | 3–7 | 2.6 ± 2.2 | 2.2 ± 1.4 | NS | 1.3 ± 2.1 | 1.1 ± 1.2 | NS | NS | NS | |
| Pastries | Ocassional | 0.8 ± 0.9 | 0.3 ± 0.3 | NS | 1.3 ± 1.7 | 1.8 ± 2.2 | NS | <0.05 | NS | |
p < 0.05: Statistically significant; NS = Not Significant. * Recommended intake according to the Spanish Society of Community Nutrition (SENC) [58].
Food consumption according to NOVA classification among celiac adults and children (mean of portions/day ± SD).
| Adults | Children and Adolescents | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vt0 | Vt3 | Vt12 | Vt0 vs. Vt3 | Vt0 vs. Vt12 | Vt0 | Vt3 | Vt12 | Vt0 vs. Vt3 | Vt0 vs. Vt12 | Vt0 | Vt3 | Vt12 | |
|
| 27 | 13 | 4 | 31 | 20 | 16 | |||||||
|
| 6.3 ± 2.4 | 7.2 ± 2.7 | 8.2 ± 1.8 | NS | 0.066 | 5.6 ± 1.9 | 6.8 ± 2.0 | 7.1 ± 2.3 | NS | 0.078 | <0.05 | <0.05 | NS |
|
| 2.8 ± 1.0 | 3.2 ± 1.2 | 3.8 ± 1.3 | NS | NS | 3.4 ± 1.3 | 4.4 ± 1.6 | 3.5 ± 1.0 | NS | NS | NS | 0.05 | NS |
|
| 1.4 ± 1.1 | 1.5 ± 0.9 | 1.8 ± 0.6 | NS | NS | 1.1 ± 0.8 | 1.1 ± 0.8 | 1.1 ± 0.9 | NS | NS | <0.05 | NS | NS |
|
| 5.0 ± 2.2 | 4.3 ± 1.8 | 3.7 ± 1.1 | <0.05 | 0.068 | 6.1 ± 2.1 | 5.9 ± 2.3 | 5.9 ± 1.8 | NS | <0.05 | NS | 0.068 | <0.05 |
Abbreviations: G1: Group 1 (unprocessed or minimally processed foods); G2: Group 2 (processed culinary ingredients); G3: Group 3 (processed foods); G4: Group 4 (ultra-processed products). p < 0.05: Statistically significant; NS = Not Significant.
GFP energy contribution to total energy intake among celiac adults and children (mean ± SD).
| Adults | Children and Adolescents | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vt0 | Vt3 | Vt12 | Vt0 vs. Vt3 | Vt0 vs. Vt12 | Vt0 | Vt3 | Vt12 | Vt0 vs. Vt3 | Vt0 vs. Vt12 | Vt0 | Vt3 | Vt12 | |
|
| 27 | 13 | 4 | 25 | 21 | 14 | |||||||
|
| 23.7 ± 10.0 | 18.9 ± 6.1 | 21.4 ± 11.4 | <0.05 | 0.08 | 17.4 ± 12.6 | 18.8 ± 14.7 | 21.4 ± 10.7 | NS | NS | <0.05 | NS | NS |
Abbreviations: GFP: Gluten-free product. p < 0.05: Statistically significant; NS = Not Significant.
FODMAP consumption (g/day) of celiac adults and children (mean ± SD).
| Adults | Children | Adults vs. Children | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vt0 | Vt3 | Vt12 | Vt0 vs. Vt3 | Vt0 vs. Vt12 | Vt0 | Vt3 | Vt12 | Vt0 vs. Vt3 | Vt0 vs. Vt12 | Vt0 | Vt3 | Vt12 | |
| n | 25 | 12 | 4 | 30 | 21 | 11 | |||||||
| Fructose | 11.3 ±5.5 | 16.4 ± 12.3 | 14.7 ± 4.9 | 0.18 | NS | 10.2 ± 5.2 | 11.8 ± 6.3 | 13.2 ± 6.4 | NS | 0.06 | NS | NS | NS |
| Glucose | 9.5 ± 4.7 | 14.2 ± 9.5 | 12.1 ± 4.8 | <0.05 | NS | 8.6 ± 4.2 | 10.6 ± 5.3 | 9.9 ± 4.8 | NS | NS | NS | NS | NS |
| Fructans | 0.8 ± 1.1 | 0.8 ± 1.0 | 13.0 ± 1.0 | NS | NS | 0.5 ± 0.6 | 0.9 ± 1.1 | 0.3 ± 0.5 | 0.08 | NS | NS | NS | NS |
| Lactose | 10.4 ± 7.5 | 12.0 ± 8.9 | 13.0 ± 9.5 | NS | NS | 18.8 ± 10.8 | 13.8 ± 6.8 | 14.8 ± 8.6 | NS | NS | <0.05 | NS | NS |
| Inulin | 0.1 ± 0.2 | 0.4 ± 0.6 | 0.3 ± 0.5 | 0.1 | NS | 0.4 ± 0.3 | 0.2 ± 0.2 | 0.3 ± 0.4 | 0.055 | NS | <0.01 | NS | NS |
| Manitol | 0.1 ± 0.2 | 0.0 ± 0.0 | 0.1 ± 0.3 | NS | NS | 0.02 ± 0.1 | 0.01 ± 0.1 | 0.04 ± 0.2 | NS | NS | NS | NS | NS |
| Raffinose | NC | NC | NC | - | - | NC | NC | NC | - | - | - | - | - |
| Stachyose | 0.02 ± 0.1 | 0.0 ± 0.0 | 0.0 ± 0.0 | NS | NS | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | NS | NS | NS | NS | NS |
| Sorbitol | 0.4 ± 0.6 | 1.3 ± 1.9 | 1.4 ± 2.1 | <0.01 | NS | 1.0 ± 1.2 | 0.7 ± 0.7 | 0.8 ± 1.1 | NS | NS | <0.05 | NS | NS |
| TOTAL FODMAP | 32.8 ± 12.1 | 45.1 ± 26.8 | 42.3 ± 18.5 | <0.05 | NS | 39.4 ± 15.2 | 38.2 ± 11.4 | 41.8 ± 13.5 | NS | NS | 0.08 | NS | NS |
Abbreviations: NC, No Comsumption. p < 0.05: Statistically significant; NS = Not Significant.
Figure 2Percentage of adult (a) and children and adolescent (b) participants presenting 0, 1–5 or more than 6 symptoms. Vt0: visit at time 0, at diagnosis; vt3: visit after 3 months on a gluten-free diet; vt12: visit after 12 months on a gluten-free diet.